Media-OutReach Newswire Secarna Pharmaceuticals publishes new preclinical data in The Journal of Immunology demonstrating potent therapeutic activity of LNAplus™ ASO targeting NLRP3 in highly debilitating autoinflammatory diseases
Media-OutReach Newswire Coface Asia Corporate Payment Survey 2023: Asian companies experience fewer payment delays and are rather optimistic despite multiple headwinds ahead
2023 VinFuture Special Prize Laureate Prof. Daniel Drucker: Ample room remains for innovation in GLP-1 therapies 1.
Bora Pharmaceuticals Exits Integration Phase with Sequentially-Improved Gross and Operating Margins 3.